3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Central Hemodynamics and Blood Flow Distribution During Infusion of Perflubron Emulsion or its Vehicle: Effects in anesthetized dogs

Pages 1343-1353 | Published online: 11 Jul 2009
 

Abstract

Mongrel dogs were anesthetized and prepared for hemodynamic monitoring and the measurement of blood flow distribution using radionuclide-labelled microspheres (15±2 μm). Four dogs were infused with a perflubron emulsion (E) (90% w/v perflubron containing egg yolk phospholipid as a stabilizer) and five dogs were infused with the vehicle (V) (same composition without the perfluorocarbon). Both infusions were given at the dose of 3 ml/Kg over a 30-minute period. Measurements of blood pressures and cardiac output were made before, at 12 minutes of the infusion and at 5, 30 and 60 minutes post-infusion. Blood flow distribution was determined before, at the 15th minute of the infusion and at 2 and 60 minutes post-infusion. One dog infused with V exhibited a hypotensive reaction and urticaria; this was excluded from the group statistics. Neither group showed statistically significant hemodynamic changes during or after the infusion, although both E and V groups showed transient elevation of the stroke volume. Blood flows were raised consistently to the heart and renal cortex and transiently to some skeletal muscles by E treatment.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.